Global Arteriosclerosis Testers Market Size By Type (PWV, CF-PWV), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Arteriosclerosis Testers Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 2.3 billion by 2031, growing at a CAGR of 9.6% during the forecast period from 2023 to 2031. The market is witnessing significant growth due to the rising prevalence of cardiovascular diseases, increasing geriatric population, and growing awareness of early diagnostic tools for arteriosclerosis. Arteriosclerosis testers, including pulse wave velocity devices and arterial stiffness monitors, are gaining traction as essential tools for non-invasive cardiovascular risk assessment.

Advancements in medical diagnostics, increasing demand for portable and user-friendly devices, and integration with digital health platforms are further propelling the growth of the arteriosclerosis testers market. Governments and healthcare institutions globally are emphasizing preventive healthcare, which has boosted the adoption of these diagnostic tools.

Drivers:

1. Rising Incidence of Cardiovascular Disorders:

With cardiovascular diseases being the leading cause of death worldwide, early detection tools such as arteriosclerosis testers are becoming crucial. Their ability to detect arterial stiffness and predict potential cardiovascular risks is driving widespread adoption in clinical and homecare settings.

2. Increasing Geriatric Population:

Aging is a major risk factor for arteriosclerosis. The expanding elderly population worldwide is fueling the demand for reliable, non-invasive diagnostic devices to monitor vascular health.

3. Technological Advancements in Diagnostic Devices:

Innovations such as portable testers, integration with mobile apps, cloud connectivity, and AI-enhanced analytics are making arteriosclerosis testing more accessible, accurate, and convenient.

Restraints:

1. High Cost of Advanced Devices:

Premium features and integrated technologies come at a higher price, which can limit adoption in low- and middle-income regions and among smaller healthcare facilities.

2. Lack of Awareness in Developing Countries:

Limited awareness about the benefits of early arteriosclerosis detection and inadequate healthcare infrastructure hinder market penetration in emerging economies.

Opportunity:

1. Growth in Preventive Healthcare and Home Monitoring:

As health monitoring shifts towards home-based care, demand for user-friendly arteriosclerosis testers is rising. This trend presents substantial opportunities for companies offering portable and easy-to-use diagnostic solutions.

2. Expansion in Emerging Markets:

Regions like Asia-Pacific and Latin America offer untapped growth potential, driven by improving healthcare infrastructure and growing emphasis on chronic disease management.

Market by System Type Insights:

By system type, Pulse Wave Velocity (PWV) Measurement Devices held the largest market share in 2023. These systems are considered the gold standard in arteriosclerosis diagnosis due to their precision and reliability in assessing arterial stiffness. The Oscillometric Arterial Stiffness Testers segment is expected to grow rapidly, supported by its simplicity, affordability, and increasing integration in wearable health devices.

Market by End-use Insights:

In terms of end-use, the Hospitals and Clinics segment led the market in 2023, accounting for over 50% of global revenue. These facilities rely on arteriosclerosis testers for early diagnosis, risk stratification, and preventive care. The Homecare Settings segment is projected to experience the fastest growth rate, supported by increasing consumer preference for home monitoring and advancements in compact diagnostic technologies.

Market by Regional Insights:

North America dominated the global arteriosclerosis testers market in 2023, driven by its well-established healthcare system, early adoption of innovative technologies, and increasing awareness of cardiovascular health. Asia-Pacific is anticipated to be the fastest-growing region during the forecast period, due to rising healthcare expenditure, government-led health initiatives, and increasing chronic disease burden in countries like China, India, and Japan.

Competitive Scenario:

Key players in the Global Arteriosclerosis Testers Market include Omron Corporation, Fukuda Denshi Co., Ltd., A&D Company, Ltd., AtCor Medical (Uscom), Vasamed Inc., IEM GmbH, Pulse Medical Technology Inc., and Medicore Co., Ltd. These companies are focusing on new product launches, technological upgrades, and strategic collaborations to strengthen their market position.

Scope of Work – Global Arteriosclerosis Testers Market

Report Metric Details

Market Size (2023) USD 1.1 Billion

Projected Market Size (2031) USD 2.3 Billion

CAGR (2023–2031) 9.6%

Market Segments By System Type, By End-use, By Region

Growth Drivers Rising cardiovascular disorders, aging population, technological advancements

Opportunities Expansion of home healthcare, emerging market potential

Key Market Developments:

2023: Omron Corporation released a next-gen wearable arteriosclerosis monitor integrated with AI-based health analytics.

2024: Fukuda Denshi partnered with a hospital chain in Southeast Asia to deploy arterial stiffness monitoring devices in primary care settings.

2025: A&D Company launched a Bluetooth-enabled PWV device compatible with telemedicine platforms.

FAQs:

1. What is the current market size of the Global Arteriosclerosis Testers Market?

The market was valued at USD 1.1 billion in 2023.

2. What is the major growth driver of the Global Arteriosclerosis Testers Market?

The rising prevalence of cardiovascular diseases and increasing demand for early diagnostic solutions are major growth drivers.

3. Which is the largest region during the forecast period in the Global Arteriosclerosis Testers Market?

North America is the largest region, owing to advanced healthcare infrastructure and high awareness levels.

4. Which segment accounted for the largest market share in the Global Arteriosclerosis Testers Market?

The Pulse Wave Velocity Measurement Devices segment led the market by system type in 2023.

5. Who are the key market players in the Global Arteriosclerosis Testers Market?

Key players include Omron Corporation, Fukuda Denshi Co., Ltd., A&D Company, Ltd., and AtCor Medical (Uscom).